Peter Hillmen
Leeds Teaching Hospitals NHS Trust(GB)Apellis Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Complement system in diseases, Immunodeficiency and Autoimmune Disorders, Chronic Myeloid Leukemia Treatments
Most-Cited Works
- → Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines(2008)3,177 cited
- → Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia(2014)1,675 cited
- → iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL(2018)1,646 cited
- → Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia(2014)1,603 cited
- → Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia(2015)1,539 cited
- → The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin(2005)1,523 cited